Cancer Treatment Reviews
Volume 29, Issue 1 , Pages 73-75, February 2003

Immunochemotherapy with OK-432 may improve survival for people with curatively resected gastric cancer:☆☆☆★

Abstracted from: Sakamoto J, Teramukai S, Nakazato H et al. Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials. Journal of Immunotherapy 2002; 25: 405–12.

Oncology Department, Infermi Hospital, Italy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: None specified.

☆☆ For correspondence: Dr J Sakamoto, Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Japan. E-mail: sakamoto@pbh.med.kyoto-u.ac.jp.

★ Abstract provided by Bazian Ltd, London.

PII: S0305-7372(02)00124-X

doi:10.1016/S0305-7372(02)00124-X

Cancer Treatment Reviews
Volume 29, Issue 1 , Pages 73-75, February 2003

Article Tools